Treatment approach to connective tissue disease-associated interstitial lung disease

被引：13

作者：

Wilson, Timothy M. ^{[1
]}

Solomon, Joshua J. ^{[2
]}

Demoruelle, M. Kristen ^{[1
]}

机构：

[1] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80204 USA

[2] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Denver, CO USA

来源：

CURRENT OPINION IN PHARMACOLOGY | 2022年 / 65卷

基金：

美国国家卫生研究院;

关键词：

RHEUMATOID-ARTHRITIS; SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; DERMATOMYOSITIS; MORTALITY; SURVIVAL; CYCLOPHOSPHAMIDE; MANIFESTATIONS; INTERLEUKIN-6; TOCILIZUMAB;

D O I：

10.1016/j.coph.2022.102245

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Interstitial lung disease (ILD) is a common manifestation in connective tissue diseases (CTD), such as rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory myositis (IM). ILD is associated with significant morbidity and mortality in nearly all CTD highlighting the critical need for effective treatment strategies in this patient population. In this review, we will summarize the approach to treatment when there is concern for CTD-ILD and highlight recent advancements in therapeutics within various forms of CTD-ILD.

引用

页数：6

共 50 条

[41] Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease
Mulcaire-Jones, Erica
Pugashetti, Janelle Vu
Oldham, Justin M.
Khanna, Dinesh
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 435 - 448
[42] Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease
Pugashetti, Janelle Vu
Khanna, Dinesh
Kazerooni, Ella A.
Oldham, Justin
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2024, 50 (03) : 439 - 461
[43] Successful Pregnancy Outcome with Connective Tissue Disease-Associated Interstitial Lung Disease
Colbenson, G.
Rose, C.
Ernste, F.
Ryu, J. H.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[44] Determining Respiratory Impairment in Connective Tissue Disease-Associated Interstitial Lung Disease
Assayag, Deborah
Ryerson, Christopher J.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (02) : 213 - +
[45] Comment on: rituximab in autoimmune connective tissue disease-associated interstitial lung disease
Uzunhan, Yurdagul
Ferrah, Lila
Brillet, Pierre-Yves
Dhote, Robin
Valeyre, Dominique
Nunes, Hilario
RHEUMATOLOGY, 2016, 55 (12) : 2279 - 2280
[46] Connective tissue disease-associated interstitial lung disease: a series of 60 patients
Chebbi, Donia
Derbal, Samar
Hentati, Olfa
Cherif, Yousra
Moussa, Ines
Kammoun, Hela
Ben Dahmen, Fatma
Fekih, Leila
Gharbi, Leila
Abdallah, Meya
Moussa, Ines
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[47] Autoantibodies Are Already Found in Connective Tissue Disease-Associated Interstitial Lung Disease
Jearn, La-He
Kim, Think-You
CHEST, 2016, 150 (03) : 753 - 755
[48] Could quality be the key in connective tissue disease-associated interstitial lung disease?
Molyneaux, Philip L.
Maher, Toby M.
RESPIROLOGY, 2018, 23 (09) : 801 - 802
[49] Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease
Pugashetti, Janelle Vu
Khanna, Dinesh
Kazerooni, Ella A.
Oldham, Justin
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 411 - 433
[50] BIOMARKERS FOR CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE: A PILOT STUDY
Chiu, Y. H.
Voortman, M.
Delemarre, E. M.
Nierkens, S.
De Jong, P.
Hoesein, F. Mohamed
Van Laar, J. M.
Spierings, J.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1430 - 1431

← 1 2 3 4 5 →